1-20 of 25
Authors: Jack Cuzick
Journal Article
Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United States Open Access
JNCI: Journal of the National Cancer Institute, Volume 117, Issue 5, May 2025, Pages 924–933, https://doi.org/10.1093/jnci/djae327
Published: 10 December 2024
Journal Article
Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation From a Statewide Registry Open Access
JNCI: Journal of the National Cancer Institute, Volume 114, Issue 4, April 2022, Pages 626–630, https://doi.org/10.1093/jnci/djab173
Published: 31 August 2021
Journal Article
The Value of Helicobacter Eradication in Long-term Aspirin Users Open Access
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 690–691, https://doi.org/10.1093/jnci/djx289
Published: 19 January 2018
Journal Article
Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer Open Access
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 2, February 2018, Pages 166–175, https://doi.org/10.1093/jnci/djx137
Published: 04 August 2017
Journal Article
Comparison of EndoPredict and EPclin With Oncotype DX Recurrence Score for Prediction of Risk of Distant Recurrence After Endocrine Therapy Open Access
JNCI: Journal of the National Cancer Institute, Volume 108, Issue 11, November 2016, djw149, https://doi.org/10.1093/jnci/djw149
Published: 10 July 2016
Journal Article
Cancer Prevention: Obstacles, Challenges, and the Road Ahead Free
JNCI: Journal of the National Cancer Institute, Volume 108, Issue 2, February 2016, djv309, https://doi.org/10.1093/jnci/djv309
Published: 07 November 2015
Journal Article
Endpoints for the Evaluation of Breast Cancer Treatments Get access
JNCI: Journal of the National Cancer Institute, Volume 106, Issue 12, December 2014, dju323, https://doi.org/10.1093/jnci/dju323
Published: 07 November 2014
Journal Article
Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer Open Access
JNCI: Journal of the National Cancer Institute, Volume 105, Issue 19, 2 October 2013, Pages 1504–1511, https://doi.org/10.1093/jnci/djt244
Published: 12 September 2013
Journal Article
Response Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 16, 22 August 2012, Pages 1267–1268, https://doi.org/10.1093/jnci/djs302
Published: 31 July 2012
Journal Article
CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients Get access
JNCI: Journal of the National Cancer Institute, Volume 104, Issue 6, 21 March 2012, Pages 452–460, https://doi.org/10.1093/jnci/djs126
Published: 06 March 2012
Journal Article
Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 22, 16 November 2011, Pages 1656–1664, https://doi.org/10.1093/jnci/djr393
Published: 29 September 2011
Journal Article
Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case–Control Study Get access
JNCI: Journal of the National Cancer Institute, Volume 103, Issue 9, 4 May 2011, Pages 744–752, https://doi.org/10.1093/jnci/djr079
Published: 11 April 2011
Journal Article
Tamoxifen and the Factor V Leiden Mutation Get access
JNCI: Journal of the National Cancer Institute, Volume 102, Issue 13, 7 July 2010, Pages 918–919, https://doi.org/10.1093/jnci/djq225
Published: 07 July 2010
Journal Article
Prevention of Breast Cancer in Postmenopausal Women: Approaches to Estimating and Reducing Risk Get access
JNCI: Journal of the National Cancer Institute, Volume 101, Issue 6, 18 March 2009, Pages 384–398, https://doi.org/10.1093/jnci/djp018
Published: 18 March 2009
Journal Article
Routine Audit of Large-Scale Cervical Cancer Screening Programs Get access
JNCI: Journal of the National Cancer Institute, Volume 100, Issue 9, 7 May 2008, Pages 605–606, https://doi.org/10.1093/jnci/djn131
Published: 07 May 2008
Journal Article
Results at Recruitment From a Randomized Controlled Trial Comparing Human Papillomavirus Testing Alone With Conventional Cytology as the Primary Cervical Cancer Screening Test Get access
JNCI: Journal of the National Cancer Institute, Volume 100, Issue 7, 2 April 2008, Pages 492–501, https://doi.org/10.1093/jnci/djn065
Published: 02 April 2008
Journal Article
Long-Term Results of Tamoxifen Prophylaxis for Breast Cancer—96-Month Follow-up of the Randomized IBIS-I Trial Get access
JNCI: Journal of the National Cancer Institute, Volume 99, Issue 4, 21 February 2007, Pages 272–282, https://doi.org/10.1093/jnci/djk049
Published: 21 February 2007
Journal Article
Human Papillomavirus Testing and Liquid-Based Cytology: Results at Recruitment From the New Technologies for Cervical Cancer Randomized Controlled Trial Get access
JNCI: Journal of the National Cancer Institute, Volume 98, Issue 11, 7 June 2006, Pages 765–774, https://doi.org/10.1093/jnci/djj209
Published: 07 June 2006
Journal Article
Re: Tamoxifen for the Prevention of Breast Cancer: Current Status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Get access
JNCI: Journal of the National Cancer Institute, Volume 98, Issue 9, 3 May 2006, Page 643, https://doi.org/10.1093/jnci/djj167
Published: 03 May 2006
Journal Article
Radiotherapy for Breast Cancer Get access
JNCI: Journal of the National Cancer Institute, Volume 97, Issue 6, 16 March 2005, Pages 406–407, https://doi.org/10.1093/jnci/dji086
Published: 16 March 2005
